Hospital care delivered at home for people with advanced cirrhosis

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic liver disease or cirrhosis who are enrolled in IU Health's Hospital at Home (H@H) program. It asks about their views and experience of the program.

Age

18 years or older.

Sex

All sexes can join.

Disease stage

Chronic liver disease or cirrhosis, shown by typical clinical, lab and imaging findings. The trial focuses on decompensated cirrhosis (end-stage liver disease).

Main reasons for not taking part

• Unable to complete study questionnaires because of a brain or memory disease, legal blindness or hearing loss.
• Transplant of an organ other than the liver, or new hemodialysis.
• Pregnant, incarcerated, or receiving hospice services.
• HIV+ with CD4 count < 200.
• Blood pressure < 90/60, pulse > 120, or oxygen need > 6L or >2L above baseline.

The registry criteria, word for word

What the trial wants to find out

The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.

The group in the trial

• Decompensated CirrhoticsOther group

  Phase 1: * two questionnaires to assess patient reported outcomes * an open-ended patient interview using a variety of patient-engagement methods to assess program expectations Phase 2: • completion of the Hospital at Home (H@H) program as part of clinical care. In brief, the Hospital at Home program (H@H) is an innovative care delivery method that aims to provide hospital-level care at home and facilitate the transition care from the hospital to the home. Phase 3: * researchers engage virtually to discuss actual experience, outcomes, and challenges. These will be semi-structured interviews about their perspectives on the program, including desired outcomes and expectations and perceived barriers and drivers and will last about two hours. * complete four questionnaires relating to quality of life.

  Treatment: Indiana University Health Hospital at Home Program